Page last updated: 2024-10-24

carmustine and Carcinoma, Small Cell

carmustine has been researched along with Carcinoma, Small Cell in 26 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research Excerpts

ExcerptRelevanceReference
"A selected case file of 32 patients with carcinoma of the lung which had passed the stage of surgical cure was randomized in 3 arms and treated with different schedules: regimen A, adriamycin plus cyclophosphamide; regimen B, the BACON combination, slightly modified; regimen CVP, cyclophosphamide plus vincristine plus prednisone."5.04Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial. ( Arosio, A; Burdick, L; Cunietti, E; Eridani, S; Maggio, L; Periti, M; Perrone, G, 1978)
" The addition of a nitrosourea appears to be an improvement over cyclophosphamide used alone in oat cell carcinoma and over the two drug combination of cyclophosphamide and methotrexate in both adenocarcinoma of the lung and oat cell disease."5.04Nitrosourea combinations in lung cancer. ( Livingston, RB, 1976)
"In small cell lung cancer initial high dose therapy followed by non-cross-resistant regimens may prove effective."2.37High dose chemotherapy in solid tumours in adults. ( Peters, W; Souhami, R, 1986)
"Small cell carcinoma is predominantly found in the lung and only about 5% of small cell carcinoma cases have been noted to be extrapulmonary; these are commonly found in the esophagus, pancreas, skin, uterus, and breast."1.34Small cell carcinoma of the nasopharynx. ( Chien, CY; Huang, HY; Hwang, CF; Lin, IH, 2007)
"Cyclocreatine was not very cytotoxic upon 24 h of exposure of human SW2 small-cell lung cancer cells to concentrations of up to 5 mM."1.29Cyclocreatine in cancer chemotherapy. ( Kaddurah-Daouk, R; Kufe, DW; Liu, J; Menon, K; Northey, D; Teicher, BA, 1995)
" In the dosage range of 600 to 1000 mg/m2 in heavily pretreated patients, BCNU is not recommended, but additional investigation may be warranted in patients with central nervous system metastases who previously were treated with radiation therapy."1.28High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma. ( Baldauf, MC; Broste, S; Friedenberg, WR; Gehlsen, JA; Koontz, DP; Kriesel, DH; Rodvold, KA; Rushing, DA, 1991)
"Thirty-one patients with metastatic brain tumors (MBT) from lung cancer and ten patients with MBT from melanoma received BCNU, 100 mg/m2, every four weeks by intracarotid and/or vertebral artery infusion into each involved site."1.26Phase II study--intra-arterial BCNU therapy for metastatic brain tumors. ( Avellanosa, AM; Caracandas, J; Ghoorah, J; Jennings, E; Karakousis, C; Madajewicz, S; Park, HC; Takita, H; Vincent, R; West, CR, 1981)

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-199013 (50.00)18.7374
1990's11 (42.31)18.2507
2000's2 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, IH1
Hwang, CF1
Huang, HY1
Chien, CY1
Presant, CA1
Hillinger, S1
Klahr, C1
Madajewicz, S1
West, CR1
Park, HC1
Ghoorah, J1
Avellanosa, AM1
Takita, H1
Karakousis, C1
Vincent, R1
Caracandas, J1
Jennings, E1
Carney, DN1
Mitchell, JB1
Kinsella, TJ1
Stewart, P1
Buckner, CD1
Thomas, ED1
Bagley, C1
Bensinger, W1
Clift, RA1
Appelbaum, FR1
Sanders, J1
Teicher, BA1
Menon, K1
Northey, D1
Liu, J1
Kufe, DW1
Kaddurah-Daouk, R1
Aabo, K2
Vindeløv, LL3
Christensen, IJ3
Spang-Thomsen, M3
Roed, H3
Gridelli, C1
Perrone, F1
D'Aprile, M1
Rossi, A1
Palmeri, S1
Curcio, C1
Veltri, E1
Ianniello, G1
Lorusso, V1
Palmieri, G1
Shaw, GL1
Gazdar, AF1
Phelps, R1
Steinberg, SM1
Linnoila, RI1
Johnson, BE1
Oie, HK1
Russell, EK1
Ghosh, BC1
Pass, HI1
Minna, JD1
Mulshine, JL1
Ihde, DC1
de Crevoisier, R1
le Cesne, A1
le Chevalier, T2
Kiss, I1
Tomasek, J1
Protheroe, AS1
Pickard, C1
Johnson, PW1
Craddock, T1
Shefta, J1
Short, K1
Lancaster, F1
Selby, PJ1
Henwood, J1
Boylston, AW1
Eridani, S1
Burdick, L1
Maggio, L1
Cunietti, E1
Periti, M1
Arosio, A1
Perrone, G1
Abeloff, MD2
Ettinger, DS2
Baylin, SB1
Hazra, T1
Livingston, RB1
Khouri, NF1
Lenhard, RE1
Jensen, PB1
Sehested, M1
Demant, EJ1
Vindeløv, L1
Hansen, HH2
Rushing, DA1
Friedenberg, WR1
Baldauf, MC1
Broste, S1
Gehlsen, JA1
Kriesel, DH1
Koontz, DP1
Rodvold, KA1
Egyházi, S1
Bergh, J1
Hansson, J1
Karran, P1
Ringborg, U1
O'Bryan, RM1
Crowley, JJ1
Kim, PN1
Epstein, RB1
Neilan, B1
Coltman, CA1
Stuckey, WJ1
Pazdur, R1
Cha, RJ1
Pico, JL1
Baume, D1
Ostronoff, M1
Beaujean, F1
Gouyette, A1
Arriagada, R1
Rebattu, P1
Hayat, M1
Lange, OF1
Souhami, R1
Peters, W1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase III Randomized Study of Hypofractionated vs Conventionally Fractionated Concurrent Chemo-radiotherapy for Limited Disease Small Cell Lung Cancer[NCT02688036]Phase 3860 participants (Anticipated)Interventional2016-02-29Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for carmustine and Carcinoma, Small Cell

ArticleYear
[Dose-effect of chemotherapy in bronchial small-cell cancer].
    Revue des maladies respiratoires, 1997, Volume: 14, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineo

1997
High dose chemotherapy in solid tumours in adults.
    Clinics in haematology, 1986, Volume: 15, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marr

1986

Trials

5 trials available for carmustine and Carcinoma, Small Cell

ArticleYear
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Car

1995
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
    Journal of cellular biochemistry. Supplement, 1996, Volume: 24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel

1996
Combined chemotherapy for unresectable carcinoma of the lung: a randomized trial.
    International journal of clinical pharmacology and biopharmacy, 1978, Volume: 16, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Small Cell; Carmustine; Cycloph

1978
Nitrosourea combinations in lung cancer.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as Topi

1976
Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study.
    Cancer, 1990, Feb-15, Volume: 65, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Cisp

1990

Other Studies

19 other studies available for carmustine and Carcinoma, Small Cell

ArticleYear
Small cell carcinoma of the nasopharynx.
    Acta oto-laryngologica, 2007, Volume: 127, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Cisplatin;

2007
Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma.
    Cancer, 1980, Jan-01, Volume: 45, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Amphotericin B; Bone Marrow; Carcinoma, Bronchogenic; Carcinoma, Small

1980
Phase II study--intra-arterial BCNU therapy for metastatic brain tumors.
    Cancer, 1981, Feb-15, Volume: 47, Issue:4

    Topics: Adenocarcinoma; Adult; Aged; Brain Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmu

1981
In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants.
    Cancer research, 1983, Volume: 43, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Line; Cell Survival; Dose-Response Re

1983
Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung.
    Cancer treatment reports, 1983, Volume: 67, Issue:12

    Topics: Autopsy; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy;

1983
Cyclocreatine in cancer chemotherapy.
    Cancer chemotherapy and pharmacology, 1995, Volume: 35, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Division; Ce

1995
Low-dose chemotherapy delays relapse of a dominated and resistant sub-population in a heterogeneous human SCLC xenograft in nude mice.
    International journal of cancer, 1994, Nov-01, Volume: 59, Issue:3

    Topics: Animals; Carcinoma, Small Cell; Carmustine; DNA, Neoplasm; Drug Resistance; Humans; Lung Neoplasms;

1994
A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
    Cancer research, 1994, Jun-15, Volume: 54, Issue:12

    Topics: Animals; Biopsy, Needle; Carcinoma, Small Cell; Carmustine; Cell Division; DNA, Neoplasm; Drug Resis

1994
Sodium and potassium excretion changes and bone marrow recovery after chemotherapy.
    Stem cells (Dayton, Ohio), 1999, Volume: 17, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell;

1999
Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue.
    British journal of haematology, 2000, Volume: 111, Issue:3

    Topics: Amino Acid Sequence; Antineoplastic Agents, Alkylating; Bone Marrow Purging; Breast Neoplasms; Carci

2000
Management of small cell carcinoma of the lung: therapy, staging, and biochemical markers.
    Cancer, 1976, Volume: 38, Issue:3

    Topics: Adult; Aged; Amine Oxidase (Copper-Containing); Carcinoma, Small Cell; Carmustine; Cyclophosphamide;

1976
Intensive induction therapy for small cell carcinoma of the lung.
    Cancer treatment reports, 1979, Volume: 63, Issue:4

    Topics: Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxor

1979
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity.
    Cancer chemotherapy and pharmacology, 1992, Volume: 31, Issue:1

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cel

1992
High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinoma.
    Cancer, 1991, Aug-15, Volume: 68, Issue:4

    Topics: Adult; Aged; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Combined Modality Thera

1991
Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:12

    Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carmustine; Cell Line; Cell Survival; DNA, Ne

1991
[Combined modality treatment of small cell lung cancer by chemotherapy, radiotherapy, immunotherapy and Chinese traditional medicine].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1989, Volume: 12, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Comb

1989
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].
    Bulletin du cancer, 1987, Volume: 74, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell;

1987
Concurrent chemo-radiotherapy in small cell lung cancer.
    Antibiotics and chemotherapy, 1988, Volume: 41

    Topics: Adult; Aged; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Female; Humans; Ifosfamid

1988
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:4

    Topics: Carcinoma, Small Cell; Carmustine; Cell Cycle; Cell Line; Colony-Forming Units Assay; Drug Evaluatio

1987